Hyloris reports full year results for 2022 & provides

Hyloris reports full year results for 2022 & provides

Strong R&D progress & attractive commercial deals, including additional Tranexamic Acid RTU out-licensing dealsPotential U.S. market approval for......

Alvotech enters into commercialization agreement with

Alvotech enters into commercialization agreement with

Advanz Pharma will commercialize AVT23, a proposed biosimilar to Xolair® (omalizumab) in the European Economic Area, UK, Switzerland, Canada, Australia,......

Envision Pharma Group Hires Leading Industry Executives

Envision Pharma Group Hires Leading Industry Executives

PHILADELPHIA, Jan. 31, 2023 (GLOBE NEWSWIRE) -- Envision Pharma Group (Envision) today announced the appointment of two senior executives while further......

  • 1
  • 2
  • menu
    menu